Masaaki Nagai
Overview
Explore the profile of Masaaki Nagai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamaguchi M, Obayashi T, Kobayashi N, Izumi N, Nagai M, Nobata H, et al.
Sci Rep
. 2023 Dec;
13(1):22697.
PMID: 38123633
We present a single-center retrospective analysis of 228 Japanese patients with peritoneal dialysis, in which we examined whether reduced left ventricular ejection fraction (LVEF) is a risk factor for peritonitis...
2.
Uenoyama Y, Matsuda A, Ohashi K, Ueda K, Yokoyama M, Kyoutou T, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563555
Aberrant glycosylation of IgA1 is involved in the development of IgA nephropathy (IgAN). There are many reports of IgAN markers focusing on the glycoform of IgA1. None have been clinically...
3.
Hotta O, Ieiri N, Nagai M, Tanaka A, Harabuchi Y
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35054911
Hematuria is an essential symptom of immunoglobulin A nephropathy (IgAN). Although the etiology of hematuria in IgAN has not been fully elucidated, it is thought that the rupture of the...
4.
Nagai M, Kobayashi N, Izumi N, Ohbayashi T, Hotta O, Hamano T
J Nephrol
. 2021 May;
35(2):441-449.
PMID: 34014510
Background: Glomerular hematuria and proteinuria are typical manifestations of IgA nephropathy (IgAN). However, hematuria severity is not considered a useful marker of the potential benefits of corticosteroid administration as proteinuria...
5.
Nagai M, Saitoh S, Takaki T, Ohbayashi T, Hotta O, Ohno N, et al.
Kidney Med
. 2020 Aug;
2(2):222-225.
PMID: 32734243
No abstract available.
6.
Wakasugi M, Nagai M, Yokota S, Omori K, Fujikawa H, Aoike I, et al.
Intern Med
. 2019 Dec;
59(7):927-932.
PMID: 31839659
Objective The earlobe crease, a wrinkle extending from the tragus to the outer border of the earlobe, is a well-known surrogate marker for a high risk of cardiovascular disease. However,...
7.
Maeda S, Yamaguchi M, Maeda K, Kobayashi N, Izumi N, Nagai M, et al.
PLoS One
. 2019 Nov;
14(11):e0224859.
PMID: 31697753
Peritonitis is a major and the most significant complication of peritoneal dialysis (PD). Although some predictors of peritonitis in PD patients are known, the association between proton pump inhibitor (PPI)...
8.
Takaki T, Ohno N, Saitoh S, Nagai M, Joh K
Clin Exp Nephrol
. 2019 Feb;
23(6):773-781.
PMID: 30734164
Background: The interaction among the glomerular components plays an important role in the development of glomerular lesions; thus, investigation of the ultrastructural three-dimensional (3D) configuration of the human glomerular cells...
9.
Wakasugi M, Kazama J, Kawamura K, Yamamoto S, Nagai M, Omori K, et al.
Ther Apher Dial
. 2017 Sep;
21(5):478-484.
PMID: 28880437
Earlobe creases are surrogate markers for high risk of cardiovascular disease. There is no data concerning earlobe creases among hemodialysis patients, who have an increased risk of cardiovascular disease. A...
10.
Muto M, Manfroi B, Suzuki H, Joh K, Nagai M, Wakai S, et al.
J Am Soc Nephrol
. 2016 Dec;
28(4):1227-1238.
PMID: 27920152
The TNF family member a proliferation-inducing ligand (APRIL; also known as TNFSF13), produced by myeloid cells, participates in the generation and survival of antibody-producing plasma cells. We studied the potential...